March 8, 2018 / 9:42 PM / 3 months ago

BRIEF-Oncomed Pharmaceuticals Reports Q4 Earnings Per Share $0.25

March 8 (Reuters) - Oncomed Pharmaceuticals Inc:

* Q4 REVENUE $20.6 MILLION VERSUS $6.2 MILLION

* ONCOMED PHARMACEUTICALS - CURRENT CASH IS ESTIMATED TO BE SUFFICIENT TO FUND OPERATIONS THROUGH AT LEAST Q3 OF 2019

* ONCOMED PHARMACEUTICALS SAYS ESTIMATES 2018 OPERATING CASH BURN TO BE ABOUT $55 MILLION, BEFORE CONSIDERING POTENTIAL MILESTONES/OPT-INS - SEC FILING Source text: (bit.ly/2Fm92Fh) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below